Autism Research

SJR Rank #2,061H-index: 111SJR: 1.643Best quartile: Q1APC: US$4,740
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

United States

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • Genetics (clinical)Q1
  • Neurology (clinical)Q1
  • Neuroscience (miscellaneous)Q1

Areas: Medicine · Neuroscience

Most published research topics

Autism Spectrum Disorder ResearchFamily and Disability Support ResearchGenetics and Neurodevelopmental DisordersChild Nutrition and Feeding IssuesChild Development and Digital TechnologyBehavioral and Psychological StudiesAttention Deficit Hyperactivity DisorderObsessive-Compulsive Spectrum DisordersLanguage Development and DisordersVirology and Viral Diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

1939-3792, 1939-3806

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.18

References per Document

63.98

Coverage

2008-2026

Scope

Autism Research covers research relevant to ASD and closely related neurodevelopmental disorders. The journal focuses on genetic, neurobiological, immunological, epidemiological and psychological mechanisms and how these influence developmental processes in ASD. The journal encourages the submission of original research papers (Research Articles and Short Reports) that take a developmental approach to the biology and psychology of autism, with a particular emphasis on identifying underlying mechanisms and integrating across different levels of analysis. Contributions are typically empirical, but the journal also publishes theoretical papers if they significantly advance thinking. The journal encourages papers reporting work on animals or cell or other model systems that are directly relevant to a better understanding of ASD. The journal also publishes reports of carefully conducted clinical trials of treatments for the core symptoms or one of the common co-morbid symptoms of ASD. Papers presenting clinical trials will be judged, in part, on whether there is an empirical justification for the reported treatment. Individuals included in research studies can span the full spectrum of ASD, including the broader phenotype, and there are no restrictions on study participants in terms of age or intellectual ability.

Metrics from SCImago Journal Rank 2025. View on SCImago